New products | Science and Enterprise

A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial p… https://t.co/iByygVnB9U
about 17 hours ago
New post on Science and Enterprise: Covid-19 Drug Biotech Raises $300M in IPO https://t.co/zwkRakiFk5 #Science #Business
about 17 hours ago
The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infec… https://t.co/9zAfSK9Nnt
about 22 hours ago
New post on Science and Enterprise: FDA to Use Lung Chip Model for Covid-19 Testing https://t.co/YGwasY1UUJ #Science #Business
about 22 hours ago
Interim results from a clinical trial show a synthetic antibody drug reduces viral burden and medical visits among… https://t.co/bm7JdQ83hT
about 2 days ago

Covid-19 Antibodies Cut Viral Load, Medical Visits

By Alan, on October 29th, 2020%

Interim results from a clinical trial show a synthetic antibody drug reduces viral burden and medical visits among non-hospitalized Covid-19 patients. . . . → Read More: Covid-19 Antibodies Cut Viral Load, Medical Visits

200M Covid-19 Vaccine Doses Donated to Int’l Effort

By Alan, on October 28th, 2020%

Sanofi and GlaxoSmithKline are offering 200 million doses of their Covid-19 vaccine for a project devoted to making vaccines equitably available worldwide. . . . → Read More: 200M Covid-19 Vaccine Doses Donated to Int’l Effort

Better Precision Medicine Outcomes Shown for Leukemia

By Alan, on October 27th, 2020%

Clinical trial results show a strategy that first tests for genomic mutations to guide treatments results in better outcomes for patients with acute myeloid leukemia. . . . → Read More: Better Precision Medicine Outcomes Shown for Leukemia

Lilly, NIH Halt Covid-19 Antibody Therapy Trial

By Alan, on October 27th, 2020%

Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients. . . . → Read More: Lilly, NIH Halt Covid-19 Antibody Therapy Trial

Precision Drug Trial Shows Solid Tumor Shrinkage

By Alan, on October 26th, 2020%

Partial results from a clinical trial show a drug to stop specific cancer-causing proteins shrinks advanced tumors in some patients across several tumor types. . . . → Read More: Precision Drug Trial Shows Solid Tumor Shrinkage

Phone Video Algorithm Screens for Stroke

By Alan, on October 23rd, 2020%

A medical informatics team designed a computer model from patient videos to help emergency room physicians quickly diagnose stroke. . . . → Read More: Phone Video Algorithm Screens for Stroke

Start-Up Developing Engineered B-Cell Therapies

By Alan, on October 22nd, 2020%

A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from engineered B-cells in the immune system. . . . → Read More: Start-Up Developing Engineered B-Cell Therapies

Carb-X Funding Nanoscale Sponge to Treat Sepsis

By Alan, on October 21st, 2020%

A company developing tiny particles made of cellular material to soak-up toxins in the body received a $4 million award to advance its sepsis treatment. . . . → Read More: Carb-X Funding Nanoscale Sponge to Treat Sepsis

Software Designed to Model, Visualize Brain Circuits

By Alan, on October 20th, 2020%

An academic-industry team designed a web-based software tool to ease the computer modeling, simulation, and visualization of the brain’s nerve cell circuits. . . . → Read More: Software Designed to Model, Visualize Brain Circuits

Covid-19 Vaccine Challenge Trial Underway

By Alan, on October 20th, 2020%

Researchers in the U.K. are beginning a human challenge trial that intentionally exposes volunteers to SARS-CoV-2 viruses to test candidate vaccines. . . . → Read More: Covid-19 Vaccine Challenge Trial Underway

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise